Dr. Shadman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-606-1000Fax+1 206-606-1025- Is this information wrong?
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2011 - 2014
- Cleveland Clinic FoundationResidency, Internal Medicine, 2008 - 2011
- University of WashingtonMPH, Cancer Epidemiology , 2006 - 2008
- Tehran University of Medical Sciences School of MedicineClass of 2004
Certifications & Licensure
- WA State Medical License 2011 - 2025
- OH State Medical License 2008 - 2011
Awards, Honors, & Recognition
- Trainee Research Award American Society of Hematology (ASH)
Clinical Trials
- Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission Start of enrollment: 2007 Feb 01
- Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2009 Jun 01
- Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post-hoc analysis o...Brown, J., Ghia, P., Jurczak, W., Kahl, B., Lamanna, N., Robak, T., Shadman, M., Tam, C., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, ...> ;Haematologica. 2024 Feb 29
- Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study.Laura Samples, Jenna M Voutsinas MPH, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K G...> ;Blood Advances. 2024 Feb 2
- Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.Xu, L., Shadman, M., Flinn, I., Levy, M., Porter, R., Burke, J., Zafar, S., Cultrera, J., Misleh, J., Kingsley, E., Yimer, H., Freeman, B., Chaudhry, A., Tumula, P., G...> ;Haematologica. 2024 Jan 25
- Join now to see all
Journal Articles
- Translating Anti-CD19 CAR T-cell Therapy into Clinical Practice for relapsed/refractory Diffuse Large B-cell LymphomaMazyar Shadman, Ajay K Gopal, Victor A Chow, Blood
Abstracts/Posters
- High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic TrialsMazyar Shadman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell LymphomaMazyar Shadman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy and Safety of Zanubrutinib in Patients with Treatment-Naive Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with Del(17p): Initial Resu...Mazyar Shadman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- High CLL Therapy Cessation Rates in Real World PracticeApril 17th, 2023
- Mustang Bio Announces Updated Interim Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T TherapyJune 13th, 2022
- Mustang Bio Reports Third Quarter 2021 Financial Results and Recent Corporate HighlightsNovember 12th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
Hospital Affiliations
- Fred Hutchinson Cancer CenterSeattle, Washington
- Fred Hutchinson Cancer CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: